| ²é¿´: 3101 | »Ø¸´: 10 | ||||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | ||||
mc991220pyÒø³æ (СÓÐÃûÆø)
|
[½»Á÷]
ÃÀ¹úUniversity of California, DavisÄÉÃ×Ò½Ò©/·Ö×ÓÓ°Ïñ·½Ïò»¶Ó²©Ê¿ºóÉêÇë ÒÑÓÐ8È˲ÎÓë
|
|||
|
ÃÀ¹úUniversity of California, DavisÄÉÃ×Ò½Ò©/·Ö×ÓÓ°Ïñ·½Ïò»¶Ó²©Ê¿ºóºÍCSCÁªºÏÅàÑø²©Ê¿ÉúÉêÇë Multiple postdoc/CSC visiting student positions are available in the Cancer Nanotechnology Program between the Department of Biochemistry and Molecular Medicine and NCI-designated Comprehensive Cancer Center at the University of California, Davis. The program is funded by multiple NIH grants aiming to develop multifunctional nanomedicine platforms for diagnosis and treatment of cancer and other diseases. The successful candidates will have the opportunities to work with world renowned experts in cancer nanotechnology as well as experts in molecular imaging. ÏîÄ¿×éÇ¿µ÷¶àѧ¿Æ½»²æ£¬²àÖØÓÚÏȽø²ÄÁϺͼ¼ÊõµÄÁÙ´²×ª»¯£¬ºÍÊÀ½çÒ»Á÷µÄUC Davis School of Veterinary Medicine, Comprehensive Cancer Center ºÍCenter for Genomic and Molecular Imaging¶¼ÓÐÉî²ã´ÎµÄºÏ×÷¡£ÏîÄ¿¾·Ñ³ä×㣬ÅäÌ×ÒÇÆ÷É豸ÆëÈ«(¿ÉÓÃÓÚÄÉÃײÄÁϵĺϳÉÓë±íÕ÷£¬¶àÖÖ¶¯ÎïʵÑ飬ҩ´ú/Ò©¶¯£¬optical imaging, MRI, SPECT, micro-PET ÒÔ¼°PET/MRIÁªÓÃ)¡£ ʵÑéÊÒÔÚ¼ÓÖÝÊ׸®Sacramento, Éú»î±ãÀû£¬Ïû·ÑˮƽÏà¶Ô²»¸ß¡£ÏîÄ¿×éµÄÁ½¸öPI (Drs. Kit S. Lam ºÍYuanpei Li) ¶¼·Ç³£nice¡£ Dr. LamÊÇDepartment of Biochemistry and Molecular MedicineµÄChairºÍCenter for Biophotonics µÄDirector£¬Æ½Ê±·Ç³£Ã¦£¬ËùÒÔÓÐÒâÏòµÄͬѧ¿ÉÒÔÁªÏµDr. Li, ÓÊÏäÊÇlypli@ucdavis.edu¡£ 1. ²©Ê¿ºó ²©Ê¿ºóµÄ¹¤×Êˮƽ²ÎÕÕNIH Guideline£¬ÏÖÔڵıê×¼Ó¦¸ÃÊÇ£º¹¤×Ê¡Ý$42,840/Äê + benefit (ÖÚËùÖÜÖª¼ÓÖÝ´óѧϵͳµÄbenefitºÜ²»´í)¡£ ÉêÇëÕßÌõ¼þ£ºThe applicants should have a recent Ph.D and strong expertise at least one of the following fields: Nanomedicine or Molecular imaging (including optical imaging, MRI, SPECT or PET). Interested individuals please send your CV, a cover letter briefly describing previous research experience and potential match for the above-mentioned research areas, and the names and contact information of three references to lypli@ucdavis.edu. 2. CSCÁªºÏÅàÑø²©Ê¿Éú CSCÁªºÏÅàÑø²©Ê¿ÉúµÄÆÚÏÞΪ1-2Ä꣬ÒÔÁ½ÄêΪ¼Ñ£¬ÕâÑù¿ÉÒÔ·¢±íһЩºÃÎÄÕ£»Èç¹ûµÚÒ»Äê×öµÄ±È½Ï³öÉ«£¬µÚ¶þÄêÏîÄ¿×é¿ÉÒÔÊʵ±·¢·Å½òÌù¡£ÏîÄ¿×éÓÐÍêÉÆµÄTraining system,¶ÔÉêÇëÈ˱³¾°Ã»ÓÐÑϸñÒªÇó£¬Èç¹ûÓÐÄÉÃ×/µ°°×/¶àëÄ/¸ß·Ö×Ó/ÓлúºÏ³ÉµÄ¹¦µ×»òÕßÊǶ¯ÎïʵÑéµÄ¾Ñé¾Í½õÉÏÌí»¨ÁË¡£ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¶àëļ¼Êõ×Éѯ |
» ²ÂÄãϲ»¶
²ÄÁÏ¿¼Ñе÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁϵ÷¼Á
ÒѾÓÐ12È˻ظ´
Ó¢Ò»ÊýÒ»408£¬×Ü·Ö284£¬¶þÕ½Õæ³ÏÇóµ÷¼Á
ÒѾÓÐ14È˻ظ´
085410 Ò»Ö¾Ô¸211 22408·ÖÊý359Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
271Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
385·Ö ÉúÎïѧ£¨071000£©Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸°²»Õ´óѧ¼ÆËã»ú¿ÆÑ§Óë¼¼Êõѧ˶£¬331·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
318Çóµ÷¼Á£¬¼ÆËã²ÄÁÏ·½Ïò
ÒѾÓÐ8È˻ظ´
291Çóµ÷¼Á
ÒѾÓÐ25È˻ظ´
Ò»Ö¾Ô¸±±¾©¿Æ¼¼´óѧ085601²ÄÁϹ¤³ÌÓ¢Ò»Êý¶þ³õÊÔ×Ü·Ö335Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
holystone
ľ³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 1793.4
- É¢½ð: 25
- ºì»¨: 1
- Ìû×Ó: 176
- ÔÚÏß: 47.1Сʱ
- ³æºÅ: 963935
- ×¢²á: 2010-03-07
- רҵ: ÉúÎﻯѧ
4Â¥2016-01-04 09:54:14
mc991220py
Òø³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 372.1
- É¢½ð: 10
- Ìû×Ó: 68
- ÔÚÏß: 42.4Сʱ
- ³æºÅ: 86771
- ×¢²á: 2005-08-16
- רҵ: ÉúÎïÒ½Óø߷Ö×Ó²ÄÁÏ
2Â¥2015-12-29 08:37:48
Chem_mao
Òø³æ (ÕýʽдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 1390.5
- É¢½ð: 607
- ºì»¨: 2
- Ìû×Ó: 334
- ÔÚÏß: 306.1Сʱ
- ³æºÅ: 1169352
- ×¢²á: 2010-12-13
- ÐÔ±ð: GG
- רҵ: ºÏ³ÉÒ©Îﻯѧ
3Â¥2016-01-02 23:27:05
damao110
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 5998.1
- É¢½ð: 459
- ºì»¨: 1
- Ìû×Ó: 32
- ÔÚÏß: 151.3Сʱ
- ³æºÅ: 856504
- ×¢²á: 2009-09-25
- ÐÔ±ð: MM
- רҵ: ÎÞ»ú²ÄÁÏ»¯Ñ§
5Â¥2016-01-08 09:34:36














»Ø¸´´ËÂ¥




¡£µÈ¹ýÍêÔªµ©¼ÙÆÚºóÏîÄ¿×é»áÔÚÒ»Ô·ÝÕÒʱ¼äרÃÅ¿ª»áÌÖÂÛͬѧÃǵÄÉêÇë²ÄÁÏ£¬È·¶¨ÏÂÒ»ÂÖºòÑ¡ÈËÃûµ¥£¬»¹Ã»ÓÐÉêÇëµÄͬѧҪץ½ôʱ¼ä¡£